73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Epigenetic age and lung cancer risk in a prospective cohort study

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe
Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy

Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy

by University of Miami Leonard M. Miller School of MedicineScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDRese

Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy

by University of Miami Leonard M. Miller School of MedicineScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDRese
Review covers progress in immunotherapy for esophageal cancer

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

byUniversity of CambridgeCredit: Pixabay/CC0 Public DomainCambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

byUniversity of CambridgeCredit: Pixabay/CC0 Public DomainCambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The
A new therapeutic strategy to improve treatment of aggressive endometrial cancer

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus
A new therapeutic target for metastatic and resistant prostate cancers

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D
Tracking the epigenetic evolution of a cancer, cell by cell

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables
Study overturns dogma of cancer metabolism theory

Study overturns dogma of cancer metabolism theory

by University of California, Los AngelesImage shows squamous cell skin cancer tumors with lactate production (a byproduct of glucose consumption) in purple. The tumor with lactate production bloc

Study overturns dogma of cancer metabolism theory

by University of California, Los AngelesImage shows squamous cell skin cancer tumors with lactate production (a byproduct of glucose consumption) in purple. The tumor with lactate production bloc
New molecule reduces the aggressiveness of pediatric cancer

New molecule reduces the aggressiveness of pediatric cancer

by André Julião,FAPESPA microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved

New molecule reduces the aggressiveness of pediatric cancer

by André Julião,FAPESPA microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved
Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of
Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

by Ola Nilsson,Umea UniversitySeparating future PDAC cases from controls in pre-diagnostic and diagnostic samples with a cross-sectional analysis. Box plots of the individual marker concentratio

Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

by Ola Nilsson,Umea UniversitySeparating future PDAC cases from controls in pre-diagnostic and diagnostic samples with a cross-sectional analysis. Box plots of the individual marker concentratio
New study shows substantial racial and ethnic disparities among survivors of second primary cancers in the US

New study shows substantial racial and ethnic disparities among survivors of second primary cancers in the US

by American Cancer SocietyResearchers highlight the need for more research to address survival disparities among multiple primary cancer survivors. Credit: American Cancer SocietyIn new findings

New study shows substantial racial and ethnic disparities among survivors of second primary cancers in the US

by American Cancer SocietyResearchers highlight the need for more research to address survival disparities among multiple primary cancer survivors. Credit: American Cancer SocietyIn new findings